The role of non-P450 enzymes in drug oxidation

被引:58
作者
Beedham, C [1 ]
机构
[1] Univ Bradford, Sch Pharm, Bradford BD7 1DP, W Yorkshire, England
来源
PHARMACY WORLD & SCIENCE | 1997年 / 19卷 / 06期
关键词
drug oxidation; non-P450; enzymes; prodrug activation; flavin monooxygenase; monoamine oxidase; aldehyde dehydrogenase; aldehyde oxidase; xanthine oxidase;
D O I
10.1023/A:1008668913093
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In addition to cytochrome P450, oxidation of drugs and other xenobiotics can also be mediated by non-450 enzymes, the most significant of which are flavin monooxygenase, monoamine oxidase, alcohol dehydrogenase, aldehyde dehydrogenase, aldehyde oxidase and xanthine oxidase. This article highlights the importance of these non-P450 enzymes in drug metabolism. A brief introduction to each of the non-P450 oxidizing enzymes is given in this review and the oxidative reactions have been illustrated with clinical examples. Drug oxidation catalyzed by enzymes such as flavin monooxygenase and monoamine oxidase may often produced the same metabolites as those generated by P450 and thus drug interactions may be difficult to predict without a clear knowledge of the underlying enzymology, in contrast, oxidation via aldehyde oxidase and xanthine oxidase gives different metabolites to those resulting from P450 hydroxylation. Although oxidation catalyzed by non-P450 enzymes can lead to drug inactivation, oxidation may be essential for the generation of active metabolite(s). The activation of a number of prodrugs by non-P450 enzymes is thus described. It is concluded that there is still much to learn about factors affecting the non-P450 enzymes in the clinical situation.
引用
收藏
页码:255 / 263
页数:9
相关论文
共 103 条
[61]   MITOCHONDRIAL ALDEHYDE DEHYDROGENASE POLYMORPHISM IN ASIAN AND AMERICAN-INDIAN POPULATIONS - DETECTION OF NEW ALDH2 ALLELES [J].
NOVORADOVSKY, A ;
TSAI, SJL ;
GOLDFARB, L ;
PETERSON, R ;
LONG, JC ;
GOLDMAN, D .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1995, 19 (05) :1105-1110
[62]   INTERACTIONS OF SOME ANALOGS OF THE ANTICONVULSANT MILACEMIDE WITH MONOAMINE-OXIDASE [J].
OBRIEN, EM ;
DOSTERT, P ;
PEVARELLO, P ;
TIPTON, KF .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (05) :905-914
[63]   IS THE OXIDATION OF MILACEMIDE BY MONOAMINE-OXIDASE A MAJOR FACTOR IN ITS ANTICONVULSANT ACTIONS [J].
OBRIEN, EM ;
TIPTON, KF ;
BENEDETTI, MS ;
BONSIGNORI, A ;
MARRARI, P ;
DOSTERT, P .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (11) :1731-1737
[64]   FAMCICLOVIR - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN HERPESVIRUS INFECTIONS [J].
PERRY, CM ;
WAGSTAFF, AJ .
DRUGS, 1995, 50 (02) :396-415
[65]   DOSAGE PRESCRIBING AND PLASMA OXIPURINOL LEVELS IN PATIENTS RECEIVING ALLOPURINOL THERAPY [J].
PETERSON, GM ;
BOYLE, RR ;
FRANCIS, HW ;
OLIVER, NWJ ;
PATERSON, J ;
VONWITT, RJ ;
TAYLOR, GR .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (04) :419-421
[66]  
PICKAR D, 1982, ARCH GEN PSYCHIAT, V39, P535
[67]  
PIETRUSZKO R, 1991, ALCOHOLISM, V206, P101
[68]   5-ETHYNYL-2(1H)-PYRIMIDINONE - ALDEHYDE OXIDASE-ACTIVATION TO 5-ETHYNYLURACIL, A MECHANISM-BASED INACTIVATOR OF DIHYDROPYRIMIDINE DEHYDROGENASE [J].
PORTER, DJT ;
HARRINGTON, JA ;
ALMOND, MR ;
LOWEN, GT ;
ZIMMERMAN, TP ;
SPECTOR, T .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (07) :1165-1171
[69]   LINEAR PHARMACOKINETICS OF PENCICLOVIR FOLLOWING ADMINISTRATION OF SINGLE ORAL DOSES OF FAMCICLOVIR 125, 250, 500 AND 750 MG TO HEALTHY-VOLUNTEERS [J].
PUE, MA ;
PRATT, SK ;
FAIRLESS, AJ ;
FOWLES, S ;
LAROCHE, J ;
GEORGIOU, P ;
PRINCE, W .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (01) :119-127
[70]  
RASHIDI MR, 1997, IN PRESS DRUG MET DI